RIMS4 and breast cancer: In addition, the BC_gBRCA2 group showed overexpression of RIMS4 indicative of estrogen-positive cancers [28] as well as CNTFR, which is shown to be deregulated in breast cancer [29], however, with unknown clinical impact.